SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Lobbying for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Jul 10, 2026

Expenses

$80,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.

Budget/Appropriations

Theranostics report language in the Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.

Medicare/Medicaid

Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)

Bills named in this filing 3

S. 1410
Find It Early Act
H.R. 2541
Nuclear Medicine Clarification Act of 2025
H.R. 879
Medicare Patient Access and Practice Stabilization Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.